Start-Up Showcase

The Immuno-Oncology Investing and Partnering Forum will play host to our 2nd Annual Start-Up Showcase as part of the program agenda. This showcase allows immuno-oncology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.

To be eligible to participate, companies must be:
  • Addressing an unmet medical need
  • Founded no earlier than 2014
  • Actively seeking funding (startups that have raised more than $2 million in private capital or that had more than $1M in revenue in 2017 are not eligible for this showcase)

Showcase spots are limited! Entrants are encouraged to submit as soon as possible for priority consideration. Selected companies will be notified via email and receive a discounted registration rate of $500.

Please note that all companies must have a valid email address and phone number to be eligible for participation in the Start-Up Showcase. A recent news article or webpage from an investor or parent company may be submitted in lieu of a company website.


Area of Immuno-Oncology
Prefix

Final Agenda Available

Premier Sponsors

Agilent_New_Tagline

Biocytogen-2021